Policy Updates Medical Policy & Clinical GuidelinesMedicaid Managed CareMay 21, 2025

Medical Policies and Clinical Utilization Management Guidelines update

Effective June 25, 2025

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third‑Party Criteria below were developed and/or revised with expanded rationales, medical necessity indications, or criteria. Some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other members of your practice and office staff.

To view a guideline, visit the Medical Policies and Clinical UM Guidelines page.

Medical Policies

The medical policy and technology assessment committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect June 25, 2025.

Publish date

Medical Policy number

Medical Policy title

Status

1/30/2025

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

Revised

1/30/2025

LAB.00037

Serologic Testing for Biomarkers of Irritable Bowel Syndrome (IBS)

Revised

4/10/2024

SURG.00140

Peripheral Nerve Blocks for Treatment of Neuropathic Pain

Reviewed

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

OHBCBS-CD-083090-25-CPN82473

PUBLICATIONS: June 2025 Provider Newsletter